MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Neoplasms, Neuroepithelial

(UMLS:C0206715)

Definition:: Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)
UMLS ID:: C0206715
MeSH ID:: D018302

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600

Synonym(s)

Neoplasms, Neuroepithelial

Neoplasm of Neuroepithelial Tissue

Neoplasm of Neuroepithelium

Neoplasm of the Neuroepithelium

Neuroepithelial Neoplasm

Neuroepithelial Neoplasms

Neuroepithelial Tissue Neoplasm

Neuroepithelial Tissue Tumor

Neuroepithelial Tumor

10.

Neuroepithelial Tumors

11.

Neuroepithelial neoplasm

12.

Tumor of Neuroepithelial Tissue

13.

Tumor of Neuroepithelium

14.

Tumor of the Neuroepithelium

15.

neuroepithelial tumor

16.

neuroepithelial tumors

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Carmustine	12325066	CTD
2	Lomustine	21710625	CTD
3	Procarbazine	12325066 21710625	CTD
4	Vincristine	12325066	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Craniopharyngioma	58.4%
2	Neuroectodermal Tumor, Melanotic	58.4%
3	Neuroendocrine Tumors	58.4%
4	Adenoma, Acidophil	54.8%
5	melanoma	53.5%
6	Carcinoid Tumor	51.2%
7	Neurilemmoma	49.1%
8	Paraganglioma	44.5%
9	Malignant Carcinoid Syndrome	43.7%
10	Basal cell carcinoma	42.9%
11	Carcinoma, Papillary	42.9%
12	Squamous cell carcinoma	42.9%
13	Cystadenoma	42.9%
14	Mesothelioma	42.9%
15	Carcinoma, Basal Cell	42.9%
16	Hutchinson's Melanotic Freckle	42.6%
17	Melanoma, Amelanotic	42.6%
18	leukemia	40%
19	Melanoma, Experimental	38.9%
20	Cystadenocarcinoma	38.5%
21	Mucoepidermoid Carcinoma	38.5%
22	Adenoma	37.7%
23	Carcinoma	37.7%
24	Epithelioma	37.7%
25	Pheochromocytoma	37.6%
26	Meningioma	36.1%
27	Carcinoid Heart Disease	34.7%
28	Chordoma	34.4%
29	Teratoma	34.4%
30	Germinoma	34.4%
31	Teratocarcinoma	34.4%
32	Bowen's Disease	34.2%
33	Carcinosarcoma	33.3%
34	Hemangiosarcoma	33.3%
35	lymphangiosarcoma	33.3%
36	Carcinoma, Ehrlich Tumor	32.5%
37	Carcinoma, Lewis Lung	32.5%
38	Carcinoma, Lobular	32.3%
39	Trophoblastic Neoplasms	32.2%
40	Histiocytic Disorders, Malignant	32%
41	Adenofibroma	30.5%
42	Fibroadenoma	30.5%
43	Choriocarcinoma	30.4%
44	Dermoid Cyst	29.8%
45	Carcinoma 256, Walker	29.3%
46	Acanthoma	28.1%
47	Composite Lymphoma	28%
48	Leukemia, Plasma Cell	27.7%
49	Neuroectodermal Tumors	27.6%
50	Neoplasms, Germ Cell and Embryonal	27.5%
51	Germ Cell Cancer	27.5%
52	Chondrosarcoma	27.3%
53	leiomyosarcoma	27.3%
54	liposarcoma	27.3%
55	synovial sarcoma	27.3%
56	Angiomyolipoma	27.3%
57	Clear Cell Sarcoma of Soft Tissue	27.3%
58	Alveolar Soft Part Sarcoma	27.3%
59	Sarcoma, Myeloid	27.3%
60	Adenocarcinoma	26.8%
61	Carcinoma in Situ	26.8%
62	Carcinoma, Transitional Cell	26.8%
63	Papilloma	26.8%
64	Pseudomyxoma Peritonei	26.8%
65	Papillomatosis	26.8%
66	Adenomatosis, Pulmonary	26.8%
67	Adenomatous Polyps	26.8%
68	Carcinoma, Large Cell	26.8%
69	Carcinoma, Small Cell	26.8%
70	Lymphoma	26.7%
71	Neoplasms, Neuroepithelial	26.1%
72	Gliomatosis cerebri	26.1%
73	Leukemia, Experimental	25.4%
74	Neoplasms, Glandular and Epithelial	25%
75	Ameloblastoma	24.6%
76	Angiokeratoma	24.6%
77	Hemangioma	24.6%
78	hemangiopericytoma	24.6%
79	Lymphangioma	24.6%
80	Mesenchymoma	24.6%
81	Nevus	24.6%
82	Hepatoblastoma	24.6%
83	Mixed Tumor, Mullerian	24.6%
84	Angiofibroma	24.6%
85	Sarcoma	24.6%
86	Acoustic Neuroma	24.5%
87	Fibrosarcoma	24.3%
88	Osteosarcoma	24.3%
89	Hamartoma	24.1%
90	Neoplasms, Hormone-Dependent	24.1%
91	Neoplasms, Multiple Primary	24.1%
92	Paraneoplastic Syndromes	24.1%
93	Precancerous Conditions	24.1%
94	Neoplasms, Second Primary	24.1%
95	Dysgerminoma	23.6%
96	Neuroma	23.6%
97	Seminoma	23.6%
98	Malignant Fibrous Histiocytoma	22.8%
99	Leukemia, Radiation-Induced	22%
100	Adenoid Cystic Carcinoma	21.5%
101	Adenocarcinoma, Clear Cell	21.5%
102	Cholangiocarcinoma	21.5%
103	Cervical Intraepithelial Neoplasia	21.5%
104	Endometrial Stromal Sarcoma	21.4%
105	Neurofibrosarcoma	21.3%
106	Rhabdomyosarcoma	21.3%
107	Giant Cell Tumor of Bone	21.3%
108	Medulloblastoma	21.3%
109	Carcinoma, Pancreatic Ductal	20.7%
110	Vipoma	20.4%
111	Sarcoma, Experimental	20.3%
112	Basal Cell Nevus Syndrome	20.3%
113	Leukemia L1210	20.3%
114	Leukemia P388	20.3%
115	Thymoma	20.2%
116	Dermatofibrosarcoma	19.8%
117	Dermatofibrosarcoma Protuberans	19.8%
118	Plasmacytoma	19.7%
119	Malignant histiocytosis	19.6%
120	Histiocytic sarcoma	19.6%
121	Cyst	19.4%
122	Neoplastic Processes	19.4%
123	Neoplastic Syndromes, Hereditary	19.4%
124	Pregnancy Complications, Neoplastic	19.4%
125	Lymphangioleiomyomatosis	19.4%
126	Ganglioneuroma	19.4%
127	Glioma	19.4%
128	Malignant Glioma	19.4%
129	Neoplasms, Experimental	19.2%
130	Klatskin Tumor	18.8%
131	Hepatocellular Adenoma	18.7%
132	Alveolar rhabdomyosarcoma	18.3%
133	Multiple Endocrine Neoplasia	17.8%
134	Sarcoma 180	17.3%
135	Phyllodes Tumor	17.1%
136	Hemangioendothelioma	17.1%
137	Lipoma	17.1%
138	Myoma	17.1%
139	Myxoma	17.1%
140	Angiolipoma	17.1%
141	Myelolipoma	17.1%
142	Neoplasms, Bone Tissue	17.1%
143	Neoplasms, Fibrous Tissue	17.1%
144	Smooth Muscle Tumor	17.1%
145	Desmoplastic Small Round Cell Tumor	17.1%
146	Chondroma	17.1%
147	Enchondroma	17.1%
148	Hodgkin Disease	16.3%
149	Lymphoma, Non-Hodgkin	16.3%
150	Prolactinoma	16.3%
151	Growth Hormone-Secreting Pituitary Adenoma	16.3%
152	Astrocytoma	16%
153	Ependymoma	16%
154	oligodendroglioma	16%
155	Ganglioglioma	16%
156	gliosarcoma	16%
157	Anaplastic astrocytoma	16%
158	Anaplastic Oligodendroglioma	16%
159	Neoplasms, Radiation-Induced	16%
160	Hydatidiform Mole	15.9%
161	neurofibroma	15.6%
162	Nephroblastoma	15.3%
163	Lymphomatoid Granulomatosis	15.1%
164	Paraneoplastic Encephalomyelitis	14.6%
165	Glioblastoma	14.4%
166	Neuroblastoma	14.4%
167	Glioblastoma Multiforme	14.4%
168	Carcinoma, Ovarian Epithelial	14.4%
169	Mammary Neoplasms, Experimental	14.4%
170	Retinoblastoma	14.1%
171	Primary amyloidosis	14.1%
172	Leukemia, Myelomonocytic, Chronic	13.6%
173	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	13.6%
174	Ganglioneuroblastoma	13.6%
175	Tuberous Sclerosis	13.5%
176	insulinoma	13.4%
177	fibroma	13.4%
178	Fibromatosis	13.4%
179	Osteoblastoma	13.4%
180	Osteoma	13.4%
181	Rhabdomyoma	13.4%
182	Chondromatosis	13.4%
183	Hemangioblastoma	13.4%
184	Lymphoma, Extranodal NK-T-Cell	13.4%
185	Abdominal Neoplasms	13.3%
186	Erythroplasia	13.3%
187	Follicular cyst	13.3%
188	Head and Neck Neoplasms	13.3%
189	Mucocele	13.3%
190	Pilonidal Cyst	13.3%
191	Soft Tissue Neoplasms	13.3%
192	Thoracic Neoplasms	13.3%
193	Thyroglossal Cyst	13.3%
194	Synovial Cyst	13.3%
195	Aberrant Crypt Foci	13.3%
196	Adrenocortical carcinoma	12.9%
197	Adenomatous Polyposis Coli	12.8%
198	Mesoblastic Nephroma	12.7%
199	Gastrinoma	12.2%
200	Glucagonoma	12.2%
201	Nasopharyngeal carcinoma	12.2%
202	Mastocytosis	11.6%
203	Sturge-Weber Syndrome	11.6%
204	Fibromatosis, Aggressive	11.5%
205	Fibromatosis, Abdominal	11.5%
206	Gastrointestinal Stromal Tumors	11.5%
207	Renal Cell Carcinoma	11.4%
208	Papillary Renal Cell Carcinoma	11.4%
209	Hemangioma, Cavernous	11.4%
210	Leukemia, T-Cell	11.4%
211	Leukemia, B-Cell	11.4%
212	Lymphoma, Follicular	11.3%
213	T-Cell Lymphoma	11.3%
214	Mantle cell lymphoma	11.3%
215	Digestive System Neoplasms	11.1%
216	Endocrine Gland Neoplasms	11.1%
217	Eye Neoplasms	11.1%
218	Nervous System Neoplasms	11.1%
219	Carcinoma, Endometrioid	11.1%
220	Multiple Endocrine Neoplasia Type 1	11.1%
221	Waldenstrom Macroglobulinemia	10.9%
222	Multiple Myeloma	10.9%
223	Bone neoplasms	10.8%
224	Leukoplakia	10.8%
225	Lymphocele	10.8%
226	Pancreatic Cyst	10.8%
227	Skin Neoplasms	10.8%
228	Hematologic Neoplasms	10.8%
229	Mastocytoma	10.7%
230	Mastocytosis, Systemic	10.7%
231	Barrett Esophagus	10.7%
232	Breast Cyst	10.7%
233	Actinic keratosis	10.7%
234	Mediastinal Cyst	10.7%
235	Neoplasm Invasiveness	10.7%
236	Neoplasm Metastasis	10.7%
237	Neoplasm Recurrence, Local	10.7%
238	Parovarian Cyst	10.7%
239	Pericardial Cyst	10.7%
240	Splenic Neoplasms	10.7%
241	Thymic Cyst	10.7%
242	Carcinogenesis	10.7%
243	Myxoid cyst	10.7%
244	Metastasis	10.7%
245	Leukemia, Myeloid, Chronic-Phase	10.6%
246	granulosa cell tumor	10.1%
247	Optic Nerve Glioma	9.9%
248	Parathyroid Neoplasms	9.6%
249	Peritoneal Neoplasms	9.6%
250	Thyroid Neoplasm	9.6%
251	Thyroid carcinoma	9.6%
252	Liver Neoplasms, Experimental	9.5%
253	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	8.8%
254	Leukemia, Large Granular Lymphocytic	8.8%
255	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	8.8%
256	Lymphoma, T-Cell, Cutaneous	8.8%
257	Lymphoma, AIDS-Related	8.8%
258	Enteropathy-Associated T-Cell Lymphoma	8.8%
259	Primary Effusion Lymphoma	8.8%
260	Corpus Luteum Cyst	8.8%
261	Ovarian Cysts	8.8%
262	Leydig Cell Tumor	8.6%
263	Pancreatic Neoplasm	8.5%
264	Retroperitoneal Neoplasms	8.2%
265	Tracheal Neoplasms	8.1%
266	Leukoplakia, Oral	8%
267	Paraneoplastic Cerebellar Degeneration	7.9%
268	Dupuytren Contracture	7.8%
269	Urticaria Pigmentosa	7.7%
270	Choledochal Cyst	7.7%
271	Denys-Drash Syndrome	7.7%
272	Mycosis Fungoides	7.6%
273	Lymphomatoid Papulosis	7.6%
274	Plasmablastic lymphoma	7.6%
275	Peutz-Jeghers Syndrome	7.5%
276	Esophageal Neoplasms	7%
277	Limbic Encephalitis	6.9%
278	Mouth Neoplasms	6.7%
279	Central Nervous System Neoplasms	6.7%
280	Vascular Neoplasms	6.7%
281	Thymus Neoplasms	6.7%
282	Burkitt Lymphoma	6.7%
283	Genital Neoplasms, Female	6.6%
284	Pancreatic Pseudocyst	6.6%
285	Thyroid Nodule	6.5%
286	Lymphatic Metastasis	6.5%
287	Neoplasms, Unknown Primary	6.5%
288	Leukemic Infiltration	6.5%
289	Breast Neoplasms, Male	6.5%
290	Neoplasm Micrometastasis	6.5%
291	Triple Negative Breast Neoplasms	6.5%
292	Lambert-Eaton Myasthenic Syndrome	6.3%
293	Testicular Neoplasms	6.3%
294	Sezary Syndrome	5.8%
295	Opsoclonus-Myoclonus Syndrome	5.6%
296	Adrenal Gland Neoplasms	5.6%
297	Gastrointestinal Neoplasms	5.6%
298	Genital Neoplasms, Male	5.6%
299	Liver neoplasms	5.6%
300	Uveal Neoplasms	5.6%
301	Urologic Neoplasms	5.6%
302	Sebaceous Gland Neoplasms	5.5%
303	Spinal Neoplasms	5.5%
304	Bone Marrow Neoplasms	5.5%
305	Polycystic Ovary Syndrome	5.4%
306	Myelitis, Transverse	5.1%
307	Xeroderma Pigmentosum	4.8%
308	Nose Neoplasms	4.7%
309	Meningeal Neoplasms	4.6%
310	Palatal Neoplasms	4.5%
311	Pituitary Adenoma	4.3%
312	Pituitary Neoplasms	4.3%
313	ovarian neoplasm	4.1%
314	Ear Neoplasms	3.9%
315	Eyelid Neoplasms	3.9%
316	Lung Neoplasms	3.9%
317	Pleural Neoplasms	3.9%
318	Cell Transformation, Viral	3.8%
319	Brain Neoplasms	3.8%
320	Salivary Gland Neoplasms	3.8%
321	Spinal Cord Neoplasms	3.8%
322	Tongue Neoplasms	3.8%
323	Uterine Neoplasms	3.8%
324	Vaginal Neoplasms	3.8%
325	Vulvar Neoplasms	3.8%
326	Uterine Cancer	3.8%
327	Fallopian Tube Neoplasms	3.8%
328	Meningeal Carcinomatosis	3.6%
329	Pharyngeal Neoplasms	3.4%
330	Central Nervous System Cysts	3.3%
331	Bile Duct Neoplasms	3.3%
332	gallbladder neoplasm	3.3%
333	Intestinal Neoplasms	3.3%
334	Penile Neoplasms	3.3%
335	Prostatic Neoplasms	3.3%
336	Stomach Neoplasms	3.3%
337	Zollinger-Ellison syndrome	3.3%
338	Polycythemia Vera	3.2%
339	Bronchial Neoplasms	3%
340	Multiple Pulmonary Nodules	3%
341	Laryngeal neoplasm	3%
342	Supratentorial Neoplasms	3%
343	Endometrial Neoplasms	2.9%
344	Bladder Neoplasm	2.9%
345	Kidney Neoplasm	2.9%
346	Ureteral Neoplasms	2.9%
347	Urethral Neoplasms	2.9%
348	Hypopharyngeal Neoplasms	2.6%
349	Pleural Effusion, Malignant	2.6%
350	Hypopharyngeal Cancer	2.6%
351	Brain Stem Neoplasms	2.5%
352	Parotid Neoplasms	2.5%
353	Prostatic Neoplasms, Castration-Resistant	2.5%
354	Nelson Syndrome	2.5%
355	Choroid Plexus Papilloma	2.3%
356	Cecal Neoplasms	2.2%
357	Duodenal Neoplasms	2.2%
358	Tonsillar Neoplasms	2.2%
359	Cerebellar Neoplasms	2.2%
360	Nasopharyngeal Neoplasms	2%
361	Colorectal Neoplasms	2%
362	Radicular Cyst	1.9%
363	Appendiceal Neoplasms	1.9%
364	Colonic Neoplasms	1.9%
365	Rectal Neoplasms	1.9%
366	Paranasal Sinus Neoplasms	1.8%
367	Anus Neoplasms	1.5%
368	Sigmoid Neoplasms	1.5%
369	Maxillary Sinus Neoplasms	1.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234